Lifecore Biomedical, Inc. De (LFCR) Short term Debt (2011 - 2024)

Lifecore Biomedical's Short term Debt history runs 14 years deep, the most recent figure standing at $773000.0 for Q4 2024.

• In Q4 2024, Short term Debt changed 0.0% year-over-year to $773000.0; the TTM figure through Nov 2024 stood at $773000.0 (changed 0.0% YoY), while the FY2024 annual figure was $773000.0, up 33.28% from the prior year.
• Short term Debt was $773000.0 for Q4 2024 at Lifecore Biomedical, roughly flat from $773000.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $99.0 million in Q4 2022 to a low of $580000.0 in Q2 2023.
• Historically, Short term Debt has averaged $33.8 million across 5 years, with a median of $29.0 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Short term Debt surged 275.37% in 2021, then plunged 99.41% in 2023.
• A 5-year view of Short term Debt shows it stood at $11.2 million in 2020, then soared by 275.37% to $42.0 million in 2021, then soared by 135.6% to $99.0 million in 2022, then plunged by 99.22% to $773000.0 in 2023, then changed by 0.0% to $773000.0 in 2024.
• The last three Short term Debt figures came in at $773000.0 (Q4 2024), $773000.0 (Q3 2024), and $773000.0 (Q2 2024), per Business Quant data.